The pharmacological treatment of schizophrenia in Chinese patients: A comparison of prescription patterns between 1996 and 1999

British Journal of Clinical Pharmacology

Volumn 54, Issue 4, 2002, Pages 437-444

  Ungvari, Gabor S ^a,e   Chung, Yiu Gar ^b   Chee, Yip Ka ^c   Fung Shing, Ng ^d   Kwong, Tang Wai ^a   Chiu, Helen F K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^c KOWLOON HOSPITAL   (Hong Kong)

^d TAI PO HOSPITAL   (Hong Kong)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antipsychotic drugs; Atypical antipsychotics; Prescription patterns; Schizophrenia

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE; CHLORPROMAZINE; CLOZAPINE; HYPNOTIC AGENT; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; RISPERIDONE;

ACUTE DISEASE; ADULT; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HONG KONG; HUMANS; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; PSYCHOTROPIC DRUGS; SCHIZOPHRENIA;

EID: 0036428623     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2002.01668.x     Document Type: Article

References (35)

1. Baldessarini RJ, Kando JC, Centorrino F. Hospital use of antipsychotic agents in 1989 and 1993: Stable dosing with decreased length of stay. Am J Psychiatry 1984; 141: 748-752.
2. Chiu HFK, Shum PS, Lam CW. Psychotropic drug prescribing to chronic schizophrenics in a Hong Kong hospital. Int J Soc Psychiatry 1991; 37: 187-191.
3. Ungvari GS, Pang AHT, Chiu HFK, et al. Psychotropic drug prescription in rehabilitation. Soc Psychiatry Psychiatr Epidemiol 1996; 31: 288-291.
4. Williams C, Johnstone B, Kesterson J, et al. Evaluation of antipsychotic and concomitant medication use patterns in patients with schizophrenia. Med Care 1999; 37: 81-86.
5. Linden M, Thiels C. Epidemiology of prescriptions for neuroleptic drugs: Tranquillizers rather than antipsychotics. Pharmacopyschiatr 2001; 34: 150-154.
6. Kass F, Charles E, Walsh T, et al. Quality review of outpatient psychopharmacological practice with APA Task Force criteria. Am J Psychiatry 1983; 140: 221-224.
7. Clark AF, Holden NL. The persistence of prescribing habits: A survey and follow-up of prescribing to chronic hospital in-patients. Br J Psychiatry 1987; 150: 88-91.
8. Johnson DAW, Wright NF. Drug prescribing for schizophrenic out-patients on depot injection. Br J Psychiatry 1990; 156: 827-834.
9. Warner JP, Slade R, Barnes TRE. Change in neuroleptic prescribing practice. Psychiatr Bull 1995; 19: 237-239.
10. Chiu H, Lee S, Leung CM, et al. Neuroleptic prescription for Chinese schizophrenics in Hong Kong. Aust NZ J Psychiatry 1992; 26: 262-264.
11. Chow LY, Ungvari GS, Chiu HFK, et al. Psychotropic drug prescription in a long-stay care facility. HK J Psychiatry 1999; 9: 15-20.
12. Yip KC, Ungvari GS, Cheung HK, et al. A survey of antipsychotic treatment for schizophrenia in Hong Kong. Chinese Med J 1997; 110: 792-796.
13. Kane JM. Schizophrenia. N Engl J Med 1995; 334: 34-41.
14. Meltzer HY, Kostakoglu AE. Combining antipsychotics: Is there evidence for efficacy? Psychiat Times 2000; 17: 1-10.
15. Dewan MJ, Koss M. The clinical impact of reported variance in potency of antipsychotic agents. Acta Psychiat Scand 1995; 91: 229-232.
16. Kapur S, Zipursky R, Roy P, et al. The relationship between D-2 receptor occupancy and plasma levels on low dose oral haloperidol. Psychopharmacology 1997; 131: 148-152.
17. McEvoy JP, Hogarty GE, Steingard S. Optimal dose of neuroleptic in acute schizophrenia. Arch Gen Psychiatry 1991; 48: 739-745.
18. Ruiz S, Chu P, Sramek J, Rotavu E, Herrera J. Neuroleptic dosing in Asian and Hispanic outpatients with schizophrenia. Mt Sinai J Med 1996; 63: 306-309.
19. Callazo Y, Tam R, Sramek J, Herrera J. Neuroleptic dosing in Hispanic and Asian inpatients with schizophrenia. Mt Sinai J Med 1996; 63: 310-313.
20. Frackiewicz EJ, Sramek JJ, Herrera JM, Kurtz NM, Cutler NR. Ethnicity and antipsychotic response. Ann Pharmacother 1997; 31: 1360-1369.
21. Sramek JJ, Sayles MA, Simpson GM. Neuroleptic dosage for Asians: A failure to replicate. Am J Psychiatry 1986; 143: 535-536.
22. Zhang-Wong J, Beiser M, Zipursky RB, Bean G. An investigation of ethnic and gender differences in the pharmacodynamics of haloperidol. Psychiatry Res 1998; 81: 333-339.
23. Lam YW, Jann MW, Chang WH, et al. Intra- and interethnic variability in reduced haloperidol to haloperidol ratios. J Clin Pharmacol 1995; 35: 128-136.
24. Aitchison KJ, Jordan BD, Sharma T. The relevance of ethnic influences on pharmacogenetics to the treatment of psychosis. Drug Metabol Drug Interact 2000; 16: 15-38.
25. Chong SA, Sachdev P, Mahendran R, Chua HC. Neuroleptic and anticholinergic drug use in Chinese patients with schizophrenia resident in a state psychiatric hospital in Singapore. Aust NZ J Psychiatry 2000; 34: 988-991.
26. Citrome L, Levine J, Allingham B. Utilization of depot neuroleptic medication in psychiatric inpatients. Psychopharmacol Bull 1996; 32: 321-326.
27. Davis JM, Matalon L, Watanabe MD, et al. Depot antipsychotic drugs. Drugs 1994; 47: 741-773.
28. Weiden P, Casey D. Polypharmacy combining antipsychotic medications in the treatment of schizophrenia. J Pract Psychiat Behav Health 1999; 5: 229-233.
29. Preskorn S, Lacey RL. Polypharmacy: When is it rational? J Pract Psychiat Behav Health 1995; 1: 92-98.
30. Stahl SM. Antipsychotic polypharmacy. Part I. Therapeutic option or dirty little secret? J Clin Psychiatry 1999; 60: 425-426.
31. Naber D, Holzbach R, Perro C, Hippius H. Clinical management of clozapine patients in relation to efficacy and side effects. Br J Psychiatry 1992; 160(Suppl 17): 54-59.
32. Peacock L, Gerlach J. Clozapine treatment in Denmark: Concomitant psychotropic medication and hematological monitoring in a system with liberal usage practices. Acta Psychiat Scand 1994; 101: 334-336.
33. WHO Consensus Statement. Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. Br J Psychiatry 1990; 156: 412.
34. Ungvari GS, Chiu HFK, Lam LCW, et al. Gradual withdrawal of long-term anticholinergic antiparkinson medication in Chinese patients with chronic schizophrenia. J Clin Psychopharmacol 1999; 19: 141-148.
35. Barnes TRE. Comment on the WHO consensus statement. Br J Psychiatry 1990; 156: 413-414.